Patients starting both medications simultaneously face a higher risk of either insufficient glucose control or unexpected hypoglycemic episodes if dosing is not carefully adjusted
\n\n\n\n The growing scientific understanding of the gut-brain axis has also renewed interest in BPC-157s dual gastrointestinal and neurological activity
Our team will take time to review your health history, explain risks and benefits clearly, and help you build a plan that feels realistic and sustainable
As a result, patients are at an increased risk of addiction and misuse, which can lead to overdose, illegal sharing of drugs, and other harmful behaviors
Do not use if you are pregnant, nursing or if you have a medical condition
Schedule Your Consultation To determine if youre a good candidate for Mounjaro or another GLP-1 receptor agonist, schedule an appointment with one of Isyas doctors today